This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Preparing a Drug Registration for the US and the EU: Parallel or sequential applications? – Part 1
Published on: Feb 2, 2015
An overview of the main challenges faced by marketing authorisation applicants for the conversion of a dossier from one region to another, and deciding between a sequential and a parallel preparation.
Nathalie Boeglin, Alice Rolland, Frederic Pailloux and David Uguen.
February 2015 – Regulatory Rapporteur
Download the full resource now
Fill in the form to download the content